Navigation Links
Boehringer Ingelheim's interferon-free hepatitis C treatment portfolio strengthened by promising interim Phase 2a data
Date:11/2/2013

esidio's NS5B inhibitor, PPI-383, is a novel pan-genotypic non-nucleoside inhibitor with potential to inhibit all of the major HCV genotypes.  This compound is currently in Phase 1 studies in healthy subjects.  For more information, please visit www.presidiopharma.com.

Contact:
Boehringer Ingelheim Pharmaceuticals, Inc.
Name: Susanne Granold
Public Relations
Phone: 203-791-5851
Email: usnews@boehringer-ingelheim.com


'/>"/>
SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Spanien, September 23, 2014 ... dass sich Fernzugriffe auf eTMF im Jahr ... ermöglicht den Sponsoren von klinischen Versuchsreihen, die ... und Vollständigkeit von Stammdateien mit Informationen über ... zu erfüllen     Die bisher ...
(Date:9/22/2014)... 22, 2014 Levi & Korsinsky is investigating ... "the Company") (NasdaqGS: SIAL ) for possible ... law in connection with the sale of the Company ... to learn more about the investigation: http://zlkdocs.com/SIAL-Info-Request-Form_ma-2199 , ... to you. Under the terms of the ...
(Date:9/22/2014)... , Sept. 22, 2014 Avanir Pharmaceuticals, ... it is offering to sell $200 million of its ... Deutsche Bank Securities and BofA Merrill Lynch are acting ... grant the underwriters a 30-day option to purchase additional ... to be sold in the offering are being sold ...
Breaking Medicine Technology:Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 2Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 3Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 4Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 5SIGMA-ALDRICH INVESTOR ALERT: Levi & Korsinsky, LLP Investigates the Board of Directors of Sigma-Aldrich Corporation In Connection with the Sale of the Company to Merck -- SIAL 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3
... S.C., Sept. 9 At approximately 3:21,PM ... Chairman and Founder of,CureHIV.us, agreed to act ... Global,Humanceuticals, Inc,s., new extremely effective, safe and ... non-government, U.S.,and foreign institutions, organizations, and corporations, ...
... Effective Antibiotics Against ,Superbugs, BOSTON, Sept. 6 ... may have discovered the path,toward developing better drugs ... resistance to common antibiotics. The,researchers have discovered a ... opens to door to new avenues of research., ...
Cached Medicine Technology:Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug 2Boston University Biomedical Engineers Find Chink in Bacteria's Armor 2Boston University Biomedical Engineers Find Chink in Bacteria's Armor 3
(Date:9/22/2014)... September 23, 2014 Career Step, ... training, will be attending and exhibiting at the ... Health Information Management Association (AHIMA) in San Diego, ... through October 1, and Career Step will be ... suite of coding training products, including CLiM™, its ...
(Date:9/22/2014)... Fashion Footwear Association of New York (FFANY) and leading ... research to the University of Pittsburgh Cancer Institute (UPCI), ... the proceeds of the 20th annual QVC Presents "FFANY ... several cancer research centers across the country, including UPCI ... has been selected to receive funds from this year,s ...
(Date:9/22/2014)... New York, NY (PRWEB) September 22, 2014 ... Women’s Radio Network launched their first evening show, “KC After ... and Marcus Edwards, “KC After Dark” will air every Tuesday ... away a free iPad for the 50th caller, and because ... it well past the call in mark with 500 callers. ...
(Date:9/22/2014)... 2014 United States District Judge ... federal mesh lawsuits ( http://www.meshinjurylawfirm.com/lawsuits/ ) filed against ... for pretrial matters, issued an order in the ... System Products Liability Litigation (United States District Court ... no. 2:12-md-02326)—requiring that four member cases be ready ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Locating the ... industry is now easier using the Quotes Pros portal ... trying to local universal life insurance pricing from different ... coverage plans that are easily viewed when using the ... specific lengths of coverage. The plan data can be ...
Breaking Medicine News(10 mins):Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Heels for a cause: FFANY, QVC Present $240,000 from shoe sales to Pitt researchers 2Health News:The Women’s Radio Network, WRNW1’s First Evening Show a Huge Success 2Health News:Federal Court Sets Trial Date for Boston Scientific Vaginal Mesh Cases in Florida, the Rottenstein Law Group LLP Reports 2Health News:Universal Life Insurance Prices for Adults Added to National Insurer Portal Online 2
... 27 April 2009 Elsevier, the world-leading publisher ... services, is pleased to announce the launch of ... the journal on infectious disease dynamics ( http://www.elsevier.com/locate/epidemics ... papers on infectious disease dynamics in the broadest ...
... global partner and customer pilots in Europe and Asia ... Live - Booth #333- With deployments of its PLUS ... and healthcare installations in the United States, and pilots ... , a leader in precision UWB real-time location ...
... hormone-lowering therapy may require close monitoring, researchers say, ... proven effective, treating prostate cancer with the testosterone-lowering ... men,s risk for developing bone fractures and fatal ... likelihood of developing either side effect remains low, ...
... BELLEVUE, Wash., April 27 HIPAApedia.com, the first ... IT community and business professionals interested in HIPAA ... Sponsored by Edifecs, the leader in providing healthcare ... provides an online environment for collaborative, transparent, and ...
... Unique Software Application Suite for the Assessment of the ... providing state-of-the-art CT and MR imaging systems to physician ... American Urological Association that the U.S. Food and Drug ... unique software application package for the assessment of urinary ...
... today announced financial and operating results for its first quarter ended ... Quarter Summary:, , ... Net income attributable to HCA Inc. ... first quarter. , Adjusted EBITDA ...
Cached Medicine News:Health News:Elsevier launches Epidemics -- the journal on infectious disease dynamics 2Health News:Time Domain Goes Global, Announces Worldwide Availability of its PLUS(TM) Ultra Wideband Real-Time Location System Sensor Platform 2Health News:Time Domain Goes Global, Announces Worldwide Availability of its PLUS(TM) Ultra Wideband Real-Time Location System Sensor Platform 3Health News:Time Domain Goes Global, Announces Worldwide Availability of its PLUS(TM) Ultra Wideband Real-Time Location System Sensor Platform 4Health News:Heart, Bone Problems May Follow Prostate Cancer Treatment 2Health News:Heart, Bone Problems May Follow Prostate Cancer Treatment 3Health News:HIPAApedia.com Goes Live - The First Dedicated Educational Community Wiki Aimed at Healthcare Information Professionals Interested in HIPAA Regulatory Issues and Solutions. 2Health News:Neuisys Announces FDA Clearance of UroCARE 2Health News:HCA Reports First Quarter 2009 Results 2Health News:HCA Reports First Quarter 2009 Results 3Health News:HCA Reports First Quarter 2009 Results 4Health News:HCA Reports First Quarter 2009 Results 5Health News:HCA Reports First Quarter 2009 Results 6Health News:HCA Reports First Quarter 2009 Results 7Health News:HCA Reports First Quarter 2009 Results 8Health News:HCA Reports First Quarter 2009 Results 9Health News:HCA Reports First Quarter 2009 Results 10Health News:HCA Reports First Quarter 2009 Results 11Health News:HCA Reports First Quarter 2009 Results 12Health News:HCA Reports First Quarter 2009 Results 13Health News:HCA Reports First Quarter 2009 Results 14
Binocular indirect ophthalmic lenses. Small pupil diagnosis & treatment....
Binocular indirect ophthalmic lenses. Ultra-High resolutions viewing of posterior pole....
... Volk's super series slit ... resolution viewing of the ... fundus diagnostic capability, specifically ... of view, fundus image ...
Volk indirect lenses. General diagnosis & treatment....
Medicine Products: